Otonomy (OTIC) News Today → Biotech's Best Kept Secret: Potential 46,751% Gain (From Behind the Markets) (Ad) Free OTIC Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative January 23, 2023 | finance.yahoo.comOtonomy, Inc. (OTIC) Stock Historical Prices & Data - Yahoo FinanceDecember 21, 2022 | finanznachrichten.deOtonomy, Inc.: Otonomy Provides Corporate UpdateDecember 19, 2022 | finance.yahoo.comOtonomy Provides Corporate UpdateDecember 19, 2022 | marketbeat.comTrading was temporarily halted for "OTIC" at 04:12 PM with a stated reason of "News pending."November 30, 2022 | investorplace.com5 Investors Betting Big on Otonomy (OTIC) StockNovember 29, 2022 | investorplace.comWhy Is Otonomy (OTIC) Stock Up 97% Today?November 10, 2022 | finance.yahoo.comOtonomy Reports Third Quarter 2022 Financial Results and Provides Corporate UpdateNovember 6, 2022 | reuters.comOTIC.OQ - Otonomy Inc | Stock Price & Latest News | ReutersOctober 14, 2022 | marketscreener.comOTONOMY, INC. : Results of Operations and Financial Condition (form 8-K) - Marketscreener.comOctober 13, 2022 | investing.comU.S. stocks higher at close of trade; Dow Jones Industrial Average up 2.83% By Investing.com - Investing.comOctober 13, 2022 | finance.yahoo.comLianBio To Shut BridgeBio-Partnered Bile Duct Cancer Drug Trial - Yahoo FinanceOctober 13, 2022 | streetinsider.comU.S. stocks higher at close of trade; Dow Jones Industrial Average up 2.83% - StreetInsider.comOctober 13, 2022 | benzinga.comOtonomy shares are trading lower after the company reported higher dose cohorts for OTO-413 demonstrated no clinically meaningful improvement for patients from baseline. - Otonomy (NASDAQ:OTIC) - BenzingaOctober 13, 2022 | marketscreener.comOtonomy Sees No Clinically Meaningful Improvement With Higher Doses of OTO-413 in Patients With Hearing Loss -- Shares Nosedive - Marketscreener.comOctober 13, 2022 | benzinga.comWhy Laser Photonics Shares Are Trading Higher By Around 44%, Here Are 50 Stocks Moving In Thursday’s Mid- - BenzingaOctober 13, 2022 | marketscreener.comOtonomy Sees No Clinically Meaningful Improvement With Higher Doses of OTO-413 in Patients With Hearing Loss - Marketscreener.comOctober 13, 2022 | globenewswire.comOtonomy Reports Results from Clinical Evaluation of OTO-413 Higher Doses in Patients with Hearing Loss - GlobeNewswireOctober 13, 2022 | finance.yahoo.comOtonomy Reports Results from Clinical Evaluation of OTO-413 Higher Doses in Patients with Hearing Loss - Yahoo FinanceOctober 13, 2022 | finance.yahoo.comOtonomy Reports Results from Clinical Evaluation of OTO-413 Higher Doses in Patients with Hearing LossOctober 7, 2022 | reuters.comOTIC.O - Otonomy Inc | Stock Price & Latest News | ReutersSeptember 27, 2022 | marketscreener.comAPPLIED GENETIC TECHNOLOGIES CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K) - Marketscreener.comSeptember 17, 2022 | marketscreener.comOTONOMY, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K) - Marketscreener.comSeptember 9, 2022 | streetinsider.comForm SC 13G/A OTONOMY, INC. Filed by: FEDERATED HERMES, INC. - StreetInsider.comSeptember 1, 2022 | finance.yahoo.comAGTC to Participate in Upcoming Investor Conferences - Yahoo FinanceAugust 11, 2022 | marketscreener.comOtonomy : Costs Associated with Exit or Disposal Activities - Form 8-K - Marketscreener.comAugust 9, 2022 | marketscreener.comOTONOMY, INC. : Costs Associated with Exit or Disposal Activities, Change in Directors or Principal Officers (form 8-K) - Marketscreener.comAugust 6, 2022 | benzinga.comShort Volatility Alert: Otonomy, Inc. - BenzingaAugust 3, 2022 | benzinga.comThis Healthcare Stock Is Trading Higher By 148%: Here Are 40 Stocks Moving PremarketAugust 2, 2022 | seekingalpha.comOTIC stock downgraded at H.C. Wainwright as tinnitus candidate fails (NASDAQ:OTIC) - Seeking AlphaAugust 2, 2022 | marketscreener.comHC Wainwright Downgrades Otonomy to Neutral From Buy - Marketscreener.comAugust 2, 2022 | uk.investing.comDaily Biotech Pulse: Celyad Resumes Colorectal Cancer Trial, Setback For Otonomy, AstraZeneca Halts Phase 3 Head, Neck Cancer Trial By Benzinga - Investing.com UKAugust 2, 2022 | marketwatch.comOtonomy Shares Plumb New Depths on Failure of Lead Program >OTIC - MarketWatchAugust 1, 2022 | gurufocus.comAGTC to Participate in Upcomin - GuruFocus.comAugust 1, 2022 | marketscreener.comPiper Sandler Adjusts Otonomy Price Target to $3 From $6, Maintains Overweight Rating - Marketscreener.comAugust 1, 2022 | seekingalpha.comVirax, Aethlon top healthcare gainers; while Otonomy, Kazia lead losers' pack - Seeking AlphaAugust 1, 2022 | finance.yahoo.comOtonomy Shares Sink After Stopping Mid-Stage Tinnitus StudyAugust 1, 2022 | benzinga.comOtonomy Reports Results From Phase 2 Clinical Trial Of OTO-313 In Patients With Tinnitus; Co. Reports 'OT - BenzingaAugust 1, 2022 | globenewswire.comOtonomy Reports Results from Phase 2 Clinical Trial of OTO-313 in Patients with Tinnitus - GlobeNewswireAugust 1, 2022 | finance.yahoo.comOtonomy Reports Results from Phase 2 Clinical Trial of OTO-313 in Patients with TinnitusAugust 1, 2022 | marketbeat.comTrading was temporarily halted for "OTIC" at 07:08 AM with a stated reason of "News pending."July 30, 2022 | americanbankingnews.comOtonomy (NASDAQ:OTIC) Research Coverage Started at StockNews.comJuly 27, 2022 | nasdaq.comWalmart Cuts Q2, FY Profit Outlook; Stock Down - NasdaqJuly 27, 2022 | finance.yahoo.comTwo Clinical Studies to Treat Mild-to-Moderate COVID-19 at Home Reveal Value of Exscalate, Dompé's AI Platform for Drug Design - Yahoo FinanceJuly 26, 2022 | benzinga.comOtonomy shares are trading lower after the company reported Q2 earnings results. - Benzinga - BenzingaJuly 26, 2022 | marketscreener.comAGTC Receives Positive Type C Meeting Feedback from the FDA for the Company's Design and Operating Procedures of its Planned cGMP Manufacturing Facility - Marketscreener.comJuly 26, 2022 | rttnews.comHealthStream EPS Tops Estimate, MEDP Revises Forecast, OTIC To Report Tinnitus Trial Data In August - RTTNewsJuly 26, 2022 | marketbeat.comOtonomy (NASDAQ:OTIC) Announces Quarterly Earnings ResultsOtonomy (NASDAQ:OTIC - Get Rating) announced its quarterly earnings results on Monday. The biopharmaceutical company reported ($0.19) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.20) by $0.01. During the same quarter in the previous year, the company posted ($0.19) EPS.July 26, 2022 | globenewswire.comOtonomy Reports Second Quarter 2022 Financial Results and Provides Corporate Update - GlobeNewswireJuly 25, 2022 | finance.yahoo.comOtonomy Reports Second Quarter 2022 Financial Results and Provides Corporate UpdateJuly 22, 2022 | benzinga.comOtonomy's Earnings Outlook - Benzinga - Benzinga Get Otonomy News Delivered to You Automatically Sign up to receive the latest news and ratings for OTIC and its competitors with MarketBeat's FREE daily newsletter. Email Address Biotech's Best Kept Secret: Potential 46,751% Gain (Ad)The world's #1 biotech investor has been praising this stock since it was just $18.56. Even though it's rocketed 266% this year, he's now recommending a different biotech entirely! Get the name of the stock here >>> OTIC Media Mentions By Week OTIC Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OTIC News Sentiment▼-0.240.76▲Average Medical News Sentiment OTIC News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OTIC Articles This Week▼00▲OTIC Articles Average Week Get Otonomy News Delivered to You Automatically Sign up to receive the latest news and ratings for OTIC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: NEPT News Today SLRX News Today CWBR News Today CMND News Today GLMD News Today NTBL News Today QLGN News Today LSDI News Today PBLA News Today ATNF News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OTIC) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaHow Biden has already won 2024Porter & CompanyThis unknown company solves the biggest issue with AIManward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Otonomy, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
